Orbactiv

Orbactiv is a prescription medication used to treat skin and skin structure infections in adults. Orbactiv belongs to a group of drugs called glycopeptide antibiotics. These work by killing certain bacteria that cause infections.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

Common side effects of Orbactiv include nausea, vomiting, diarrhea, headache, and infusion site pain and redness.

Orbactiv can also cause dizziness. Do not drive or operate heavy machinery until you know how Orbactiv affects you.

Orbactiv is a prescription medication used to treat skin and skin structure infections in adults caused by susceptible Gram-positive bacteria.  

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

• The Medicines Company

Serious side effects have been reported with Orbactiv. See the “Orbactiv Precautions” section.

Common side effects of Orbactiv include nausea, vomiting, diarrhea, headache, and infusion site pain and redness.

This is not a complete list of Orbactiv side effects. Ask your doctor or pharmacist for more information.

Tell your doctor if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take warfarin (Coumadin).

This is not a complete list of Orbactiv drug interactions. Ask your doctor or pharmacist for more information.

Serious side effects have been reported with Orbactiv including the following:

• headache
• vomiting
• skin abscesses on the limbs
• subcutaneous abscesses
• diarrhea
• cellulitis
• osteomyelitis
• increased heart rate

Orbactiv can cause dizziness. Do not drive or operate heavy machinery until you know how Orbactiv affects you.

Do not take Orbactiv if you:

• are allergic to Orbactiv or to any of its ingredients

Heparin should not be administered within 48 hours after Orbactiv administration.

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Orbactiv, there are no specific foods that you must exclude from your diet when receiving this medication.

Before taking Orbactiv, tell your doctor about all of your medical conditions. Especially tell your doctor if you:

• are allergic to Orbactiv or to any of its ingredients
• are allergic to other glycopeptide antibacterials, including vancomycin (Vancocin), telavancin (Vibativ), or dalbavancin (Dalvance)
• have or have had condition B
• have liver problems
• have heart problems
• are pregnant or breastfeeding

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Orbactiv falls into category C. There are no well-controlled studies that have been done in pregnant women. Orbactiv should be used during pregnancy only if the possible benefit outweighs the possible risk to the unborn baby.

Tell your doctor if you are breastfeeding or plan to breastfeed.

It is not known if Orbactiv crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Orbactiv.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

The dose your doctor recommends may be based on the following:

• the condition being treated
• your age

The recommended dose of Orbactiv for the treatment of skin and skin structure infections is 1200 mg infused intravenously over 3 hours.

If you take too much Orbactiv, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

If Orbactiv is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

This medication is only for administration in a healthcare setting.